Lymphoma / Myeloma

The Lymphoma Program combines excellent patient care with research and is dedicated to finding a cure for the both Hodgkin and non-Hodgkin lymphomas. Among our accomplishments throughout the past 30 years are new state-of-the-art diagnostic capabilities benefiting patients throughout Arizona, identifying optimal treatment for localized (limited) non-Hodgkin lymphoma, and setting the benchmark for treatment of advanced non-Hodgkin lymphoma used for 25 years. The multidisciplinary clinical treatment and research team offers combined modality treatments, high-dose treatments with bone marrow/stem cell transplants, monoclonal antibody treatment and investigational new therapies for recurrent/resistant disease.

Featured Clinical Trials

A Phase Ib/II Study Evaluating the Safety and Efficacy of Obinutuzumab in Combination With Polatuzumab Vedotin and Venetoclax in Patients With Relapsed or Refractory Follicular Lymphoma and Rituximab in Combination With Polatuzumab Vedotin and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Tucson

Medical Oncology
Medical Oncology
Daniel O. Persky, MD
Medical Oncology

Phoenix

Surgical Oncology

Staff

Tucson

Clinical Research Nursing

Patricia Robles-Medina, BA, MEd, MSRN
520-694-9075

Clinical Research Coordination

Lora D. Inclan, BA
520-694-9053
Jennifer L Kramer
520-626-6725
Jamison Phelps, BS
520-694-9050

Research Data Coordination

Rosalita Campos
520-626-7446